ArticleIndian dermatology online journal

Selumetinib-A Comprehensive Review of the New FDA-Approved Drug for Neurofibromatosis.

Surajit Gorai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.